Implementation of a population-based cancer registry network in Mexico 2017-2020
DOI:
https://doi.org/10.21149/15258Palabras clave:
neoplasms, cancer registry, surveillance, MexicoResumen
The growing cancer burden particularly among less developed countries requires local data to plan and evaluate cancer control measures. This article describes the development of a population-based cancer registry network (PBCRN) in Mexico that took place between 2017 and 2020 and present related data. The PBCRN, led by the National Cancer Institute (Incan), included nine registries representing 11.3% of the Mexican population. Definitions, coding, and operative processes were based on international standards. All cities were visited to set up local structure; personnel were hired by Incan and trained in basic cancer registration in Merida. A specific software was developed. Regular virtual meetings took place for data verification and quality control. Data collection included institutions of the public and private health system. Personnel included 34 registrars, nine local leaders, and 12 staff members at the Incan. A total of 13 517 cases were recorded between 2017-2020, 64% percent of them were among females. Breast cancer was the more frequent malignancy (23.3%), followed by digestive organs with (18.4%) and female genital cancers (13.5%). Childhood (0-14 years) and adolescents cancer represented 4.4% of the total new cancer cases. The network was suspended in 2020. The present effort lacked sustainability and data were only partial. However, the experience provides valuable insights to be considered for the renewed cancer registration efforts that are currently ongoing in Mexico.
Descargas
Citas
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53. https://doi.org/10.1002/ijc.31937
Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021;18(10):663-72. https://doi.org/10.1038/s41571-021-00514-z
Leal YA, Torres J, Gamboa R, Mantilla-Morales A, Piña-Sanchez P, Arrieta O, et al. Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry. Arch Med Res. 2022;53(8):859-66. https://doi.org/10.1016/j.arcmed.2022.11.015
Instituto Nacional de Estadística y Geografía. Características de las defunciones registradas en México durante 2017. Comunicado de prensa núm. 525/18. México: Inegi [cited Oct 16, 2022]. Available from: https://www.inegi.org.mx/contenidos/programas/mortalidad/doc/defunciones_ registradas_2017_nota_tecnica.pdf
Meneses-García A, Ruiz-Godoy LM, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A. Principales neoplasias malignas en México y su distribución geográfica (1993-2002). Rev Invest Clin. 2012;64(4):322-9. [cited Oct 16, 2022]. Available from: https://www.medigraphic.com/pdfs/revinvcli/nn-2012/nn124b.pdf
Fajardo-Gutiérrez A, González-Miranda G, Pachuca-Vázquez A, Allende-López A, Fajardo-Yamamoto LM, Rendón-Macías ME. Cancer incidence and mortality in children in the Mexican Social Security Institute (1996-2013). Salud Publica Mex. 2016;58(2):162-70. https://doi.org/10.21149/spm.v58i2.7785
Secretaría de Salud. Plan Sectorial De Salud. Cáncer en la Infancia y la Adolescencia 2013-2018. México: Secretaría de Salud, 2014 [cited Nov 22, 2022]. Available from: http://www.ssch.gob.mx/rendicionCuentas/archivos/ Cancer%20en%20la%20Infancia%20y%20la%20Adolescencia.pdf
Secretaría de Salud de Jalisco. Registro estatal de cáncer en Jalisco. México: Secretaría de Salud de Jalisco [cited May 10, 2023]. Available from: https://ssj.jalisco.gob.mx/salud-publica/registros-estatales-de-salud/ registro-estatal-de-cancer-en-jalisco
Leal YA, Reynoso-Noverón N, Aguilar-Castillejos LF, Meneses-García A, Mohar A, Piñeros M. Implementation of the population-based cancer registry in the city of Mérida, Mexico: process and early results. Salud Publica Mex. 2019;62(1):96-104. https://doi.org/10.21149/10501
Instituto Nacional de Cancerología. Programa Integral de Prevención y Control de Cáncer en México. México: Incan, 2016 [cited May 10, 2023]. Available from: https://www.iccpportal.org/system/files/plans/PICCM_FINAL Incan_Enero2018.pdf
Secretaría de Gobernación. Decreto por el que se reforman y adicionan diversas disposiciones de la Ley General de Salud. México: Diario Oficial de la Federación, 22 de junio de 2017 [cited May 10, 2023]. Available from: https://www.dof.gob.mx/nota_detalle.php?codigo=5487731&fecha=22/06/2017#gsc.tab=0
Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and developing population-based cancer registration in low- or middle-income settings. Lyon, France: International Agency for Research on Cancer, 2014;(43):1-46 [cited Mar 10, 2023]. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK566957/
Fritz AP C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. Clasificación Internacional de Enfermedades para Oncología (CIE-O). Washington, DC: Organización Panamericana de la Salud/Organización Mundial de la Salud, 2003 [cited May 10, 2023]. Available from: https://apps.who.int/iris/bitstream/handle/ 10665/96612/9789241548496_eng.pdf
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, 3rd ed. Cancer. 2005;103(7):1457-67. https://doi.org/10.1002/cncr.20910
Giraldo P, Latre P, Franco-García E, Alvarez R, Pascual M, Castilla T, et al. HAEMACARE Project: Reclassifing Hematologic Neoplasias According Morphological Data. Blood. 2007;110(11):4392. https://doi.org/10.1182/blood.v110.11.4392.4392
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors, 8th ed. Chichester: John Wiley & Sons, 2017.
International Agency for Research in Cancer. Global Initiative for Cancer Registry Development. IARC Regional Hubs for Cancer Registration. Geneva: WHO [cited May 10, 2023]. Available from: https://gicr.iarc.fr/
Working Group of the International Association of Cancer Registries. Guidelines on confidentiality for population-based cancer registration. Eur J Cancer Prev. 2005;14(4):309-27. https://doi.org/10.1097/00008469-200508000-00003
Congreso de la Ciudad de México. Ley de Protección de Datos Personales en Posesión de Sujetos Obligados en la Ciudad de México. México: Gobierno Federal de los Estados Unidos Mexicanos, 11 de febrero de 2021, México [cited May 10, 2023]. Available from: https:// www.congresocdmx.gob.mx/media/documentos/a8b6a4657686ea6f01e7a- 024377b814e0664d634.pdf
European Network of Cancer Registries. Development/recommendations on cancer registration standards: coding incidence date. France: ENCR [cited Oct 28, 2022]. Available from: https://www.encr.eu/
Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumor registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol. 2000;29(2):197-207. https://doi.org/10.1093/ije/29.2.197
Chatterjee S, Chattopadhyay A, Senapati SN, Samanta DR, Elliott L, Loomis D, et al. Cancer Registration in India - Current Scenario and Future Perspectives. Asian Pac J Cancer Prev. 2016;17(8):3687-96.
Omonisi AE, Liu B, Parkin DM. Population-based cancer registration in Sub-Saharan Africa: its role in research and cancer control. JCO Glob Oncol. 2020;6:1721-8. https://doi.org/10.1200/GO.20.00294
Piñeros M, Laversanne M, Barrios E, de Camargo Cancela M, de Vries E, Pardo C, et al. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 2022;13. https://doi.org/10.1016/j.lana.2022.100294
Piñeros M, Abriata MG, Mery L, Bray F. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica. 2017;41. Available from: https://iris.paho.org/handle/10665.2/33832
Frech S, Muha CA, Stevens LM, Trimble EL, Brew R, Perin DP, et al. Perspectives on strengthening cancer research and control in Latin America through partnerships and diplomacy: experience of the National Cancer Institute’s Center for Global Health. J Glob Oncol. 2018;4:1-11. https://doi.org/10.1200/JGO.17.00149
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
Muñoz-Aguirre P, Huerta-Gutierrez R, Zamora S, Mohar A, Vega-Vega L, Hernández-Ávila JE, et al. Acute lymphoblastic leukaemia survival in children covered by Seguro Popular in Mexico: a national comprehensive analysis 2005-2017. Health Syst Reform. 2021;7(1):1-10. https://doi.org/10.1080/23288604.2021.1914897
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18(6):719-31. https://doi.org/10.1016/S1470-2045(17)30186-9
Rivera-Luna R, Perez-Vera P, Galvan-Diaz C, Velasco-Hidalgo L, Olaya-Vargas A, Cardenas-Cardos R, et al. Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children. Front Oncol. 2022;12. https://doi.org/10.3389/fonc.2022.1072811
Anane-Sarpong E, Wangmo T, Ward CL, Sankoh O, Tanner M, Elger BS. “You cannot collect data using your own resources and put It on open access”: Perspectives from Africa about public health data-sharing. Dev World Bioeth. 2018;18(4):394-405. https://doi.org/10.1111/dewb.12159
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Salud Pública de México
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Al proponer un trabajo para su publicación, los autores aceptan las condiciones contenidas en las presentes normas y ceden a Salud Pública de México los derechos patrimoniales sobre el artículo en cuestión, a fin de que ésta lo edite, publique, reproduzca, difunda, comercialice, traduzca o autorice su traducción a cualquier idioma.
Los derechos transferidos incluyen la publicación del artículo por cualquier medio, sea éste impreso, magnético o electrónico, o por cualquier otro soporte o medio de difusión que exista o pueda crearse en el futuro, así como la realización de publicaciones mediante la concesión de licencias totales o parciales a terceros.
Los artículos aceptados serán publicados en Salud Pública de México bajo una licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.
Los trabajos propuestos deberán ser originales e inéditos, y no podrán presentarse a ninguna otra revista mientras se encuentren sometidos a la consideración de Salud Pública de México.También se reciben trabajos completos publicados previamente en forma de resumen, o trabajos no publicados presentados en congresos o seminarios.
Todos los trabajos serán publicados con pleno conocimiento de los autores.
Los artículos firmados son responsabilidad de los autores y no necesariamente reflejan la opinión de la revista, del Instituto Nacional de Salud Pública o de la institución a la que están afiliados los autores.